HIGHLIGHTS
- who: Qiuhua Luo and colleagues from the Department of Pharmacy, The First Affiliated Hospital of China Medical University, Shenyang, China have published the paper: Hydrochlorothiazide/Losartan Potassium Tablet Prepared by Direct Compression, in the Journal: Pharmaceutics 2022, 14, x FOR PEER REVIEW of /2022/
- how: The pharmacokinetic data were analysed by drug and statistics (DAS) version software.
SUMMARY
The hydroxychlorothiazide (HCTZ)/losartan potassium (LOS-K) tablet was the first compound preparation comprised of an antagonist to angiotensin II receptor (AT1) and a diuretic, which was approved by the FDA in April . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.